Wegovy is made by Novo Nordisk, a Danish pharmaceutical company, using a network of manufacturing sites rather than one factory with a very busy conveyor belt. The UK leaflet for Wegovy FlexTouch pens lists manufacturers in Bagsværd, Denmark, and Chartres, France. However, the addresses in a leaflet do not tell you where every ingredient, pen and batch has been.
If you have ever wondered where your treatment comes from before it reaches your fridge, the answer involves biotechnology, specialist manufacturing and careful distribution. Here is how the pieces fit together, with a little background on the company behind the name.
Table of Contents
2. Which countries are involved in making Wegovy?
3. Why does one medicine need more than one factory?
5. What checks happen before a medicine reaches patients?
6. What matters when your Wegovy pen arrives?
7. Does the same advice apply to Wegovy tablets?
8.1. Is Wegovy made in Denmark?
8.2. Is Novo Nordisk the same company as Eli Lilly?
8.3. Is Wegovy made from yeast?
8.4. Can you tell which factory made your pen?
Who is Novo Nordisk?
Novo Nordisk’s roots go back to insulin production in Denmark in 1923. Novo and Nordisk began as separate businesses, competed for decades and merged in 1989. So the company’s history goes back much further than the recent interest in weight-loss treatments.
That background helps explain why the same company name appears on both diabetes and weight-management medicines. It also makes the manufacturing story more interesting than a simple address search: the business grew alongside advances in producing biological medicines and making them practical for patients to use.
Which countries are involved in making Wegovy?
For UK FlexTouch pens, the patient leaflet names Novo Nordisk A/S in Bagsværd, Denmark, and Novo Nordisk Production SAS in Chartres, France. These are the manufacturers listed in the leaflet, but that does not mean every manufacturing stage for every pack takes place at those addresses.
Novo Nordisk also has a large manufacturing operation in Kalundborg, Denmark. Its November 2023 expansion announcement covered everything from active pharmaceutical ingredients to packaging, with most of the investment going into ingredient production. The projects were due to be completed in stages between late 2025 and 2029, so the announcement does not confirm that every new facility is already up and running.
Why does one medicine need more than one factory?
Making an active ingredient and preparing a finished injection are different jobs. In June 2024, Novo Nordisk announced a second fill-and-finish facility in Clayton, North Carolina, to increase capacity for current and future injectable treatments for obesity and other chronic diseases. Construction was due to be completed in stages between 2027 and 2029.
That US project shows the scale and specialisation of the wider network, but it is not evidence that a particular UK Wegovy pen came from Clayton. A company’s list of factories, an expansion announcement and the manufacturing details for your own pack each answer a different question.
How is semaglutide made?
Semaglutide is Wegovy’s active ingredient. The UK product information describes it as a human GLP-1 analogue produced using recombinant DNA technology in Saccharomyces cerevisiae cells, a species of yeast. In other words, it is made through controlled biological production, rather than by simply mixing familiar ingredients in a large container.
The finished FlexTouch product is a solution for injection in a pre-filled pen. Producing the active ingredient, preparing the finished medicine and making the pen all need to come together. A pen that looks simple in your hand relies on a much more involved manufacturing process behind the scenes.
What checks happen before a medicine reaches patients?
Medicines manufacturing and distribution are covered by separate but connected standards. Good manufacturing practice (GMP) sets the minimum standard manufacturers must meet in their production processes, while good distribution practice (GDP) makes sure medicines come from the licensed supply chain and are stored, transported and handled under suitable conditions. The MHRA inspects manufacturing and distribution sites to check they comply.
The practical point is that where a medicine is made is only part of the picture. A well-known company name does not remove the need for careful handling, correct storage and a legitimate supply route. The medicine needs to stay in good condition throughout its journey, including after it leaves the factory.
What matters when your Wegovy pen arrives?
For the FlexTouch pens covered by the UK leaflet, unopened pens should be stored in a refrigerator at 2°C to 8°C, away from the cooling element. Do not freeze them or use a pen that has been frozen. Once in use, a pen can be kept for six weeks, either below 30°C or in the refrigerator. Keep the pen cap on to protect the medicine from light.
If you are unsure about a delivery, or think your pen may have been exposed to the wrong temperature, contact the dispensing pharmacy before using the medicine. Explain what happened, how long it lasted and which product was involved; you cannot tell from its appearance alone whether it has been stored correctly. Our Wegovy treatment information explains how the assessment works if you are considering treatment.
Does the same advice apply to Wegovy tablets?
Do not assume a tablet and an injection share the same storage rules simply because both contain semaglutide. The tablet product information describes a different formulation with its own handling instructions. Follow the leaflet supplied with your prescribed form of Wegovy rather than applying the pen’s refrigeration guidance.
Our Wegovy tablet information covers this separate format. If you have enjoyed following the journey from factory to fridge, our article on where Mounjaro is made tells another manufacturer’s story. The products have different ingredients and instructions, so their manufacturing journeys should not be treated as interchangeable.
Frequently asked questions
Is Wegovy made in Denmark?
Denmark is part of the answer. The UK FlexTouch leaflet lists one manufacturer in Denmark and one in France, and Novo Nordisk also has a wider production network. It would be inaccurate to claim that every stage of every UK pack takes place in one Danish factory.
Is Novo Nordisk the same company as Eli Lilly?
No. Novo Nordisk is the company behind Wegovy, whereas Mounjaro is made by Eli Lilly. They are separate businesses. Comparing the medicines can be useful, but a similar injection format does not mean they share an active ingredient, a factory or the same product instructions.
Is Wegovy made from yeast?
The product information says semaglutide is produced in yeast cells using recombinant DNA technology. This is a controlled biotechnology process. It does not mean a Wegovy pen contains ordinary baking yeast, and it is not something that could be reproduced at home.
Can you tell which factory made your pen?
A general account of how Wegovy is made cannot trace an individual pack through every stage. Check the packaging and leaflet supplied with your pen, and ask your dispensing pharmacy or the manufacturer if you need a query about a specific batch investigated. Keep the batch number and packaging rather than relying on a photograph of someone else’s medicine.
Does Wegovy always need to stay in the fridge?
Storage depends on the form of Wegovy and whether it is in use. The UK FlexTouch leaflet says pens should be refrigerated before opening, and allows six weeks below 30°C or in the refrigerator once in use. Tablets have separate instructions. Follow your own leaflet and ask the pharmacy if you are unsure whether your medicine has been stored correctly.
Sources and further reading
Novo Nordisk: Wegovy FlexTouch UK patient leaflet
Novo Nordisk: Kalundborg expansion announcement, 10 November 2023
Novo Nordisk: Clayton expansion announcement, 24 June 2024
Novo Nordisk: Wegovy FlexTouch UK product information


